arrow
R

Roberto Rodríguez-Jiménez

CIBERSAM-ISCIII
H指数:45
被引数:6,251

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimizing tDCS cognitive outcomes in schizophrenia: the role of dopaminergic tone and antipsychotic load

优化精神分裂症患者的tDCS认知结局:多巴胺能基调和抗精神病药物负荷的作用

2026-06-120
OAAI
Risperidone-ISM® effectiveness and tolerability in acute schizophrenia patients hospitalised due to a relapse: results from an international, prospective, non-interventional evaluation (RESHAPE study)

利培酮-ISM®在因复发而住院的急性期精神分裂症患者中的有效性与耐受性:一项国际性、前瞻性、非干预性评估(RESHAPE研究)的结果

2026-02-240
PRE
Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study

竞争性PANSS阴性症状模型的验证性因子分析:OPTiMiSE首次发作精神分裂症研究的数据

2025-12-120
OAAI
Enhanced recovery after surgery and long-term oncologic outcomes: Post-hoc analysis of the POWER study
2025-10-010
PRE
The DEPRE'5 study: pragmatic, multicentre, five-arm, parallel-group randomised controlled trial with blinded assessment to compare treatment strategies in major depression after a failed selective serotonin reuptake inhibitor treatment

DEPRE'5研究:一项实用型、多中心、五臂、平行组随机对照试验,采用盲法评估,旨在比较在选择性5-羟色胺再摄取抑制剂治疗失败后的重度抑郁症治疗策略。

2025-06-010
PRE
Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia
2025-05-010
PRE
Triangulating the associations of different types of childhood adversity and first-episode psychosis with cortical thickness across brain regions

三角测量不同类型的儿童逆境和首发精神病与大脑区域皮质厚度的关联

2024-12-160
PRE
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations

首发伴幻听的精神病患者皮质灰质进行性丧失

2024-05-012
PRE
Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia
2024-05-011
PRE
Evidence of spatial clustering of childhood acute lymphoblastic leukemia cases in Greater Mexico City: report from the Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia
2024-02-141
OAAI